2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate

C105H107N17O27 — CID 158158763

IUPAC2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate
SMILESCOC(=O)CCC(=O)Nc1cccc2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C(O)C(N)C(=O)O)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C(O)C(O)C(=O)O)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)CCC(=O)O)cccc12
InChIInChI=1S/C27H28N4O6.C26H27N5O7.C26H26N4O8.C26H26N4O6/c1-17-16-30(26(35)18-7-4-3-5-8-18)13-14-31(17)27(36)25(34)20-15-28-24-19(20)9-6-10-21(24)29-22(32)11-12-23(33)37-2;1-14-13-30(24(35)15-6-3-2-4-7-15)10-11-31(14)25(36)21(32)17-12-28-20-16(17)8-5-9-18(20)29-23(34)22(33)19(27)26(37)38;1-14-13-29(24(35)15-6-3-2-4-7-15)10-11-30(14)25(36)20(31)17-12-27-19-16(17)8-5-9-18(19)28-23(34)21(32)22(33)26(37)38;1-16-15-29(25(35)17-6-3-2-4-7-17)12-13-30(16)26(36)24(34)19-14-27-23-18(19)8-5-9-20(23)28-21(31)10-11-22(32)33/h3-10,15,17,28H,11-14,16H2,1-2H3,(H,29,32);2-9,12,14,19,22,28,33H,10-11,13,27H2,1H3,(H,29,34)(H,37,38);2-9,12,14,21-22,27,32-33H,10-11,13H2,1H3,(H,28,34)(H,37,38);2-9,14,16,27H,10-13,15H2,1H3,(H,28,31)(H,32,33)/t17-;14-,19?,22?;14-,21?,22?;16-/m1111/s1
InChIKeyFVZYJOPQFJPILE-WTRPANCNSA-N
MW2039.10 g/mol
LogP6.05
Rot. Bonds28

About 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate

2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate (PubChem CID 158158763) has the molecular formula C105H107N17O27 and a molecular weight of 2039.10 g/mol. Its IUPAC name is 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate.

Molecular Properties

Compound Name2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate
PubChem CID158158763
Molecular FormulaC105H107N17O27
Molecular Weight2039.10 g/mol
Exact Mass2037.75
IUPAC Name2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate
SMILESCOC(=O)CCC(=O)Nc1cccc2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C(O)C(N)C(=O)O)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C(O)C(O)C(=O)O)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)CCC(=O)O)cccc12
InChIInChI=1S/C27H28N4O6.C26H27N5O7.C26H26N4O8.C26H26N4O6/c1-17-16-30(26(35)18-7-4-3-5-8-18)13-14-31(17)27(36)25(34)20-15-28-24-19(20)9-6-10-21(24)29-22(32)11-12-23(33)37-2;1-14-13-30(24(35)15-6-3-2-4-7-15)10-11-31(14)25(36)21(32)17-12-28-20-16(17)8-5-9-18(20)29-23(34)22(33)19(27)26(37)38;1-14-13-29(24(35)15-6-3-2-4-7-15)10-11-30(14)25(36)20(31)17-12-27-19-16(17)8-5-9-18(19)28-23(34)21(32)22(33)26(37)38;1-16-15-29(25(35)17-6-3-2-4-7-17)12-13-30(16)26(36)24(34)19-14-27-23-18(19)8-5-9-20(23)28-21(31)10-11-22(32)33/h3-10,15,17,28H,11-14,16H2,1-2H3,(H,29,32);2-9,12,14,19,22,28,33H,10-11,13,27H2,1H3,(H,29,34)(H,37,38);2-9,12,14,21-22,27,32-33H,10-11,13H2,1H3,(H,28,34)(H,37,38);2-9,14,16,27H,10-13,15H2,1H3,(H,28,31)(H,32,33)/t17-;14-,19?,22?;14-,21?,22?;16-/m1111/s1
InChIKeyFVZYJOPQFJPILE-WTRPANCNSA-N
XLogP6.05
TPSA635.23 Ų
H-Bond Donors15
H-Bond Acceptors25
Rotatable Bonds28
Heavy Atoms149
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002039.10
LogP ≤ 56.05
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate?
The IUPAC name of 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate (CID 158158763) is 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate.
What is the SMILES notation for 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate?
The canonical SMILES for 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate is COC(=O)CCC(=O)Nc1cccc2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C(O)C(N)C(=O)O)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)C(O)C(O)C(=O)O)cccc12.C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2c(NC(=O)CCC(=O)O)cccc12.
What is the InChIKey of 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate?
The InChIKey is FVZYJOPQFJPILE-WTRPANCNSA-N. The full InChI is InChI=1S/C27H28N4O6.C26H27N5O7.C26H26N4O8.C26H26N4O6/c1-17-16-30(26(35)18-7-4-3-5-8-18)13-14-31(17)27(36)25(34)20-15-28-24-19(20)9-6-10-21(24)29-22(32)11-12-23(33)37-2;1-14-13-30(24(35)15-6-3-2-4-7-15)10-11-31(14)25(36)21(32)17-12-28-20-16(17)8-5-9-18(20)29-23(34)22(33)19(27)26(37)38;1-14-13-29(24(35)15-6-3-2-4-7-15)10-11-30(14)25(36)20(31)17-12-27-19-16(17)8-5-9-18(19)28-23(34)21(32)22(33)26(37)38;1-16-15-29(25(35)17-6-3-2-4-7-17)12-13-30(16)26(36)24(34)19-14-27-23-18(19)8-5-9-20(23)28-21(31)10-11-22(32)33/h3-10,15,17,28H,11-14,16H2,1-2H3,(H,29,32);2-9,12,14,19,22,28,33H,10-11,13,27H2,1H3,(H,29,34)(H,37,38);2-9,12,14,21-22,27,32-33H,10-11,13H2,1H3,(H,28,34)(H,37,38);2-9,14,16,27H,10-13,15H2,1H3,(H,28,31)(H,32,33)/t17-;14-,19?,22?;14-,21?,22?;16-/m1111/s1.
What are the key properties of 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate?
2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate has a molecular weight of 2039.10 g/mol, XLogP of 6.05, 28 rotatable bonds, 15 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-3-hydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-2,3-dihydroxy-4-oxobutanoic acid;4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoic acid;methyl 4-[[3-[2-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-oxoacetyl]-1H-indol-7-yl]amino]-4-oxobutanoate is sourced from PubChem (CID 158158763), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).